Assure Holdings Acquires Certain Assets of Innovation Neuromonitoring, LLC

$IONM
Medical/Dental Instruments
Health Care
Get the next $IONM alert in real time by email

DENVER, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, today announced that it has acquired certain assets of Innovation Neuromonitoring, LLC ("Innovation") for approximately $1.2 million in a cash and equity transaction.

John Farlinger, Assure's executive chairman and CEO, commented, "The purchase of assets from Innovation is a strong strategic fit with our existing business and provides us with the opportunity to scale our operations rapidly. Innovation currently services more than 3,000 surgeries each year including Texas, our largest market. Importantly, we are deploying capital in a manner that we believe will increase value for our current shareholders and help us move towards delivering positive cash from operations more quickly."

About Assure Holdings

Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients' neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure's mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company's website at www.assureneuromonitoring.com.

About Innovation Neuromonitoring

Innovation Neuromonitoring is a CNIM owned company that was established in 2015 in the Dallas-Fort Worth Area. Innovation's vision has been focused and centered on outstanding patient care. Leading these services are the highly trained CNIM's and Physicians representing Innovation Neuromonitoring. Since its inception, Innovation Neuromonitoring has expanded its services throughout Texas, South Carolina and Nevada. Its outstanding services are highly recognized by its surgeons and have led to Innovation Neuromonitoring's services being expanded almost exclusively by surgeon and hospital referrals.

Forward-Looking Statements

This news release may contain "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. Forward-looking statements include, but are not limited to, management's expectations regarding the increase in procedures, and other similar statements. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks include risks regarding our patient volume or cases not growing as expected, or decreasing, which could impact revenue and profitability; unfavorable economic conditions could have an adverse effect on our business; risks related to increased leverage resulting from incurring additional debt; the policies of health insurance carriers may affect the amount of revenue we receive; our ability to successfully market and sell our products and services; we may be subject to competition and technological risk which may impact the price and amount of services we can sell and the nature of services we can provide; regulatory changes that are unfavorable in the states where our operations are conducted or concentrated; our ability to comply and the cost of compliance with extensive existing regulation and any changes or amendments thereto; changes within the medical industry and third-party reimbursement policies and our estimates of associated timing and costs with the same; our ability to adequately forecast expansion and the Company's management of anticipated growth; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 31, 2023, and with the Canadian securities regulators and available on the Company's profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Contacts

Brett Maas, Managing Principal

Hayden IR

ionm@haydenir.com

(646) 536-7331



Primary Logo

Get the next $IONM alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IONM

DatePrice TargetRatingAnalyst
More analyst ratings

$IONM
Press Releases

Fastest customizable press release news feed in the world

See more
  • Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes

    Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the "Assure Convertible Debentures"). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer ("Amended Offer Letter") as follows: (i) updates the Amended Offer Letter to reflect a change in the consideration being offered for each $1,000 claim from 238.44 shares of common stock consisting of principal amount, and accrued and unpaid interest through, and including, July 19, 2024 to 1,000 shares of common stock consisting

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

    DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on September 6, 2024. Except for the extension

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

    DENVER, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 23, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on August 23, 2024. Except for the extension of

    $IONM
    Medical/Dental Instruments
    Health Care

$IONM
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$IONM
SEC Filings

See more

$IONM
Leadership Updates

Live Leadership Updates

See more
  • Assure Holdings Announces Results of Annual General Meeting of Shareholders

    DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the "Meeting") and that all matters submitted to the shareholders of the Company for approval as set out in the Company's definitive proxy statement dated December 2, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, including: Electing the following nominees to the board of directors of the Company to serve until the Company's next annual general meeting of

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

    DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts. Prior to joining Assure, Ms. Sweet worked at Premier, Inc. serving as director of Group Purchasing Organization ("GPO") sales for national accounts. Before that, Ms. Sweet was regional vice president of sales at HealthTrust where her efforts were instrumental in driving more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Scienc

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director

    DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure's vice president of clinical operations, Stephanie Krouse. In his new role, Mr. Watt leads day-to-day operations for Assure's clinical technologist team, ensuring quality of service and overseeing the Company's training and development program. In addition, Mr. Watt will play an important role in the establishment of new competencies that will drive Assure's expansion into adjacent m

    $IONM
    Medical/Dental Instruments
    Health Care

$IONM
Financials

Live finance-specific insights

See more
  • Assure & Danam Reschedule Corporate Update Call & Webcast

    DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call InformationDate: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free:   1-877-481-4010International: 1-919-882-2331Replay Passcode: 50637Webcast Replay: h

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16

    DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive proc

    $IONM
    Medical/Dental Instruments
    Health Care
  • Assure & Danam to Host Corporate Update Call & Webcast

    DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management will host a joint corporate update call with Danam on Thursday, May 16, 2024 at 4:00 PM Eastern Time to provide a corporate update. Conference Call InformationDate: Thursday, May 16, 2024Time: 4:00 PM Eastern TimeToll Free: 877-545-0523International: 973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free: 877-481-4010International: 919-882-2331Replay Passcode: 50637Webc

    $IONM
    Medical/Dental Instruments
    Health Care

$IONM
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more